Boothwyn Pharmacy recalls

Boothwyn Pharmacy has 4 recalls on record with the FDA and USDA, the earliest in 2025 and the latest reported on 10 Sep 2025. 4 are still ongoing. The most frequent reason is potency & assay.

Total recalls4since 2025

Last 12 months0reported

Class I00% of total

Ongoing4latest 10 Sep 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 4 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 3 75%Class III 1 25%

Why boothwyn pharmacy is recalled

Potency & Assay4100%

Product types

Diabetes Medication375%

By year

20254100%

Ongoing boothwyn pharmacy recalls

4 active

Reported	Class	Recall	Company	Reason	Where
10 Sep 2025Drug	CLASS II	Semaglutide, 2.5 mg/mL injection, Boothwyn Pharmacy recalled	Boothwyn Pharmacy	Potency & Assay	Nationwide
10 Sep 2025Drug	CLASS II	Semaglutide, 2.5 mg/mL injection, Boothwyn Pharmacy recalled	Boothwyn Pharmacy	Potency & Assay	Nationwide
10 Sep 2025Drug	CLASS III	Fluorescein 2% Ophth, Boothwyn Pharmacy recalled	Boothwyn Pharmacy	Potency & Assay	Nationwide
10 Sep 2025Drug	CLASS II	Semaglutide, 2.5 mg/mL injection, Boothwyn Pharmacy recalled	Boothwyn Pharmacy	Potency & Assay	Nationwide

All boothwyn pharmacy recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
10 Sep 2025Drug	CLASS II	Semaglutide, 2.5 mg/mL injection, Boothwyn Pharmacy recalled	Boothwyn Pharmacy	Potency & Assay	Nationwide
10 Sep 2025Drug	CLASS II	Semaglutide, 2.5 mg/mL injection, Boothwyn Pharmacy recalled	Boothwyn Pharmacy	Potency & Assay	Nationwide
10 Sep 2025Drug	CLASS III	Fluorescein 2% Ophth, Boothwyn Pharmacy recalled	Boothwyn Pharmacy	Potency & Assay	Nationwide
10 Sep 2025Drug	CLASS II	Semaglutide, 2.5 mg/mL injection, Boothwyn Pharmacy recalled	Boothwyn Pharmacy	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.